Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat
- PMID: 24455480
- PMCID: PMC3892736
- DOI: 10.5681/bi.2013.021
Involvement of 5HT3 Receptors in Anti-Inflammatory Effects of Tropisetron on Experimental TNBS-Induced Colitis in Rat
Abstract
Introduction: There is a pressing need for research leading to the development of new effective drugs with lower side effects and more efficacy for treating inflammatory bowel disease (IBD). The analgesic and anti-inflammatory properties of 5-Hydroxytryptamine (5-HT)-3 receptor antagonists have been shown in in vivo and in vitro studies. The present study was designed to investigate the effects of tropisetron, a 5-HT3 receptor antagonist, on an immune-based animal model of IBD.
Methods: In the present study, the trinitrobenzenesulfonic acid (TNBS) model of colitis in the rat was used. Two hours after induction of colitis in rats, tropisetron (2 mg/kg), dexamethasone (1 mg/kg), meta-chlorophenylbiguanide (mCPBG, 5 mg/kg), a 5-HT3 receptor agonist, or tropisetron + mCPBG were intraperitoneally (i.p.) administrated for 6 days. Animals were then sacrificed; macroscopic, histological, biochemical (myeloperoxidase [MPO]) assessments and ELISA test (tumor necrosis factor-alpha, interleukin-6 and interleukin-1 beta) were performed on distal colon samples.
Results: Tropisetron or dexamethasone treatment significantly reduced macroscopic and microscopic colonic damages. In addition, a significant reduction in MPO activity and colonic levels of inflammatory cytokines was seen. The beneficial effects of tropisetron were antagonized by concurrent administration of mCPBG.
Conclusion: The present study indicates that the protective effects of tropisetron on TNBS-induced colitis can be mediated by 5-HT3 receptors.
Keywords: 5-HT3 receptor; TNBS-induced colitis; Tropisetron; Ulcerative colitis.
References
-
- Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology . 1998;115:182–205. - PubMed
-
- Podolsky DK. Inflammatory bowel disease. N Engl J Med . 2002;347:417–29. - PubMed
-
- Forbes E, Murase T, Yang M, Matthaei KI, Lee J, Lee AN. et al. Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase. J Immunol . 2004;172:5664–75. - PubMed
-
- Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Ulcerative colitis: Diagnosis and treatment. Am Fam Physician . 2007;76:1323–30. - PubMed
-
- Langmead L, Rampton DS. Review article: Complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther . 2006;23:341–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous